Serial Number:
76412499
Mark:
LYNKEUS BIOTECH
Status:
Cancelled-Section 8
Status Date:
09-21-2012
Filing Date:
Registration Number:
2986751
Registration Date:
08-23-2005
Chemicals, namely, biochemical and molecular biological products for use in manufacture of pharmaceutical and veterinary pharmaceutical preparations for the diagnosis and therapy of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases; chemicals, namely, biochemical products and molecular biological products in the nature of nucleic acid probes and antibodies for the detection of degenerative diseases of the central nervous system, the eye, vasculature, and for the detection of autoimmune diseases for scientific use Pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases; veterinary pharmaceutical preparations for use in the treatment of degenerative diseases of the central nervous system, namely, diseases of the eye, diseases related to defects in vasculature or diseases related to vasculature and autoimmune diseases in domestic pets, live-stock, poultry, amphibians, teleosts and insects; preparations for healthcare, namely, dietetic products for medical purposes in the nature of dietary supplements, diet pills, dietary drink mix for use as a meal replacement, dietary food supplements, food for medically restricted diets, and meal replacement bars Educational services, namely, conducting seminars, lectures, academies, colloquiums, conferences, congresses, symposiums, workshops, practical training, in the field of molecular biology, genetic engineering, and molecular diagnostics Scientific research; technical research in the field of chemistry, biology and diagnosis of neuronal, especially opthalmological indications like retinal degradations and of diseases related to defects in vasculature or diseases related to vasculature and of autoimmune diseases; scientific research in the field of gene therapy; laboratory research in the field of molecular biology, animal models and cell culture systems; chemist services, biochemist services; technical consultation and research in the fields of biology; mission oriented research and diagnostics, namely, diagnostic services in the field of diagnostic services in the field of diseases of the eye, diseases related to defects in vasculature, and autoimmune diseases and genetic, biochemical, and medical research; chemical and biochemical laboratories; genealogy research in the nature of generating of gene therapy-protocols; computer software development for data processing; consultation in the fields of molecular biology, genetic engineering, molecular diagnostics, gene therapy, and molecular medicine; research in the field of gene therapy and molecular medicine
Mark Description:
The mark consists of stylized words and a design. The words "LYNKEUS BioTech" are in the color blue. The design consists of a first strand which runs from the upper left to the lower right, and the first strand crosses a second strand which runs form the upper right to the lower left. The first strand is in the color blue and the second strand is in the color red. The right and bottom sides of the word "LYNKEUS" and the design are black, as are the concave surfaces of the letter "S" and the first strand, and provide a three-dimensional appearance, as if the word "LYNKEUS" and the design are illuminated from the upper left, thereby highlighting the upper and left surfaces of the simulated three-dimensional logo, and leaving the lower and right surfaces in simulated shadow, further against a dropped shadow on a background of gray.
Class:
Scientific and technological services
Type of Mark:
Trademark
Published for Opposition Date:
05-31-2005
Owner:
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
N/A
Business Name:
CLARK & ELBING LLP
Correspondent Name:
